![Devyn Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Devyn Smith
Director Ejecutivo en
Arbor Biotechnologies, Inc.
.
Perfil
Devyn M.
Smith is Chief Executive Officer at Arbor Biotechnologies, Inc. since 2021.
Dr. Smith is Chairman at Alliance for Regenerative Medicine since 2023.
Dr. Smith is Director at Aspect Biosystems Ltd. since 2022.
Dr. Smith is Director at Airna, Inc. Dr. Smith was Head-Business Operations & Strategy at Pfizer Inc. from 2009 to 2017.
Dr. Smith was Chief Operating Officer at Sigilon Therapeutics, Inc. Dr. Smith was Principal at Frankel Group LLC from 2003 to 2009.
Dr. Smith completed undergraduate studies at Brigham Young University, graduate studies at Idaho State University, and doctorate studies at Harvard Medical School.
Cargos activos de Devyn Smith
| Empresas | Cargo | Inicio |
|---|---|---|
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Presidente | 01/01/2023 |
Arbor Biotechnologies, Inc.
 Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Director Ejecutivo | 27/04/2021 |
Aspect Biosystems Ltd.
 Aspect Biosystems Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops bio printed tissue therapeutics | Director/Miembro de la Junta | 21/09/2022 |
Airna, Inc.
 Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Devyn Smith.
| Empresas | Cargo | Fin |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | 01/01/2017 |
Frankel Group LLC | Corporate Officer/Principal | 01/08/2009 |
| SIGILON THERAPEUTICS, INC. | Director de Operaciones | - |
Formación de Devyn Smith.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
78
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Brigham Young University
 Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Idaho State University
 Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Aspect Biosystems Ltd.
Aspect Biosystems Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops bio printed tissue therapeutics | Commercial Services |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
Arbor Biotechnologies, Inc.
Arbor Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovering and developing the next generation of genetic medicines | Health Technology |
Frankel Group LLC | |
Airna, Inc.
Airna, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of RNA editing therapeutics | Commercial Services |
- Bolsa de valores
- Insiders
- Devyn Smith
